Market Growth Driven by Rising Chronic Disease Prevalence, Increasing Geriatric Population, High Burden of Infectious Diseases, and Growing Focus on Point-of-Care IVD Assays REDDING, Calif., June 30, ...
Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering, Technology, and Application - Global Outlook to 2031" report has been ...
DUBLIN--(BUSINESS WIRE)--The "IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering Technology, Application - Global Forecast to 2031" report has been added to ...
Biodesix has expanded its collaboration with Bio-Rad Laboratories for the development and clinical validation of in vitro diagnostic (IVD) assays, designed to facilitate the identification of a ...
is expected to grow at a CAGR of 5.5% during forecast period 2023–2030 to reach $6.45 billion by 2030 Nepal IVD Market is expected to grow at a CAGR of 12.3% from 2022 to 2029 to reach $62.7 million ...
CD Bioparticles launches end-to-end Custom Latex Immunoturbidimetric Assay development services for research applications.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, ...
QIAGEN N.V. QGEN has announced a new partnership with South Korea-based GENCURIX, Inc. to develop oncology assays for use on the QIAcuityDx digital PCR (dPCR) platform. The molecular diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results